Go to InsilicoMedicine
About
InsilicoMedicine
Insilico Medicine is an artificial intelligence company focusing on drug discovery, biomarker development, digital medicine and aging research. It is developing a full-stack engine and naturally plug-and-play into the "Big Pharma", "Big Tech" and consumer companies.
Note from the editor

Insilico Medicine is an artificial intelligence company focusing on drug discovery, biomarker development, digital medicine and aging research. It is developing a full-stack engine and naturally plug-and-play into the "Big Pharma", "Big Tech" and consumer companies.

Editors
Go to the profile of Alex Zhavoronkov, PhD
Alex Zhavoronkov, PhD
Founder of Insilico Medicine, adj. prof at the Buck. I speak at 40+ events per year on AI for drug discovery and longevity research. PubMed: Zhavoronkov+A
Go to the profile of Alexander Aliper
Go to the profile of Poly Mamoshina
Poly Mamoshina
Young geneticist
Go to the profile of Ivan Ozerov
Go to the profile of Polina Firsanova
Writers
Go to the profile of Alexander Aliper
Go to the profile of Poly Mamoshina
Poly Mamoshina
Young geneticist
Go to the profile of Poly Mamoshina
Go to the profile of Artur Kadurin
Go to the profile of Daniil Polykovskiy
Go to the profile of Quentin Vanhaelen